IMC Chicago’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.5M Buy
+25,449
New +$26M 0.01% 828
2025
Q3
Sell
-17,293
Closed -$12.9M 3758
2025
Q2
$13.5M Buy
+17,293
New +$13.4M 0.01% 881
2025
Q1
Sell
-48,715
Closed -$40.5M 3322
2024
Q4
$37.6M Buy
48,715
+34,391
+240% +$28.5M 0.02% 419
2024
Q3
$12.7M Buy
+14,324
New +$12.9M 0.01% 729
2019
Q1
Sell
-4,103
Closed -$499K 789
2018
Q4
$475K Buy
+4,103
New +$458K ﹤0.01% 634

Other funds holding LLY

IMC Chicago's LLY Position: Q2 2026 in Review

IMC Chicago opened a new position in Eli Lilly (LLY) in Q2 2026: 25,449 shares worth $30.5M. The stake represents 0.01% of the portfolio and ranks #828 among its holdings. This is a return to the name: IMC Chicago previously reported a position in LLY as recently as Q2 2025.

IMC Chicago first reported a position in LLY in Q4 2018 and has held it in 5 quarters since. The position peaked at $37.6M in Q4 2024. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • IMC Chicago held 25,449 shares of Eli Lilly worth $30.5M as of Q2 2026.
  • Eli Lilly was a new IMC Chicago position in Q2 2026.
  • Eli Lilly made up 0.01% of IMC Chicago's portfolio in Q2 2026, its #828 holding.
  • IMC Chicago first reported a position in Eli Lilly in Q4 2018 and has held it in 5 quarters since.
  • IMC Chicago's Eli Lilly position peaked at $37.6M in Q4 2024.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.